Experiment 371983

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationADLER,Y: GUINDO,J: FINKELSTEIN,Y: KHOURI,A: ASSALI,A: BAYES-GENIS,A: DE LUNA,A:. (1998). COLCHICINE FOR LARGE PERICARDIAL EFFUSION.. 21(2)
Amount utilized
Compound isolated
DiseaseON THE BASIS OF REPORTED EXPERIENCE WITH COLCHICINE FOR RECURRENT PERICARDITIS, WE ADMINISTERED COLCHICINE TO TWO PATIENTS WITH LARGE PERICARDIAL EFFUSIONS COMPLICATING IDIOPATHIC PERICARDITIS. THE FIRST WAS A 26 YEAR OLD MALE WHO SHOWED CLINICAL DETERIORATION FOLLOWING EMERGENCY PERICARDIOCENTESIS AND ASPIRIN (3 G.DAY) FOR 10 DAYS; THE SECOND WAS A 2 YEAR OLD GIRL WHO WAS UNSUCCESSFULLY TREATED WITH ASPIRIN (100 MG/KG/DAY) FOR 2 WEEKS, FOLLOWED BY CORTICOSTEROIDS FOR 7 MONTHS. ADMINISTRATION OF COLCHICINE (1 MG/DAY) INSTEAD OF ASPIRIN IN THE FIRST CASE, AND WITH A RAPID TAPERING-OFF OF THE CORTICOSTEROIDS IN THE SECOND CASE, LED TO COMPLETE REGRESSION OF THE PERICARDIAL EFFUSION ON ECHOCARDIOGRAPHY WITHIN 1 WEEK AND 1 MONTH, RESPECTIVELY. COLCHICINE WAS DISCONTINUED AFTER 1 MONTH IN THE FIRST PATIENT AND WAS CONTINUED FOR 6 MONTHS IN THE CHILD. NEITHER HAS HAD A RECURRENCE AT 24 AND 6 MONTHS OF FOLLOW-UP, RESPECTIVELY. NO SIDE EFFECTS OF COLCHICINE WERE OBSERVED. WE CONCLUDE THAT COLCHICINE MAY BE EFFECTIVE IN THE TREATMENT OF LARGE PERICARDIAL EFFUSION WHEN THERAPY WITH NONSTEROIDAL ANTI-INFLAMMATORY DRUGS AND/OR CORTICOSTEROIDS FAILS.
Dose amount1.0 MG
Number1
Qualitative resultACTIVE
AnimalHUMAN ADULT
Per unitDAY
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES